The Chinese Journal of Natural Medicines, published by the esteemed CHINESE JOURNAL NATURAL MEDICINES, plays a pivotal role in the exploration and advancement of complementary and alternative medicine. With an ISSN of 2095-6975 and an E-ISSN of 1875-5364, this journal is recognized for its commitment to high-quality research and innovative findings in the realms of drug discovery and miscellaneous medical fields. Operating from China, it has earned a prestigious reputation in the academic community, achieving Q1 status in Complementary and Alternative Medicine and Q2 rankings in both Drug Discovery and Miscellaneous Medicine as of 2023, solidifying its influence within the scientific discourse. Researchers and professionals will find valuable insights here as the journal explores the intersection of traditional natural medicines with modern pharmacological science, making it an essential resource for anyone dedicated to the field. With a convergence period from 2004 to 2024, the journal continues to champion open dialogue and disseminate significant findings critical for the development of effective natural therapies.

BMC Complementary Medicine and Therapies is a leading open-access journal published by BMC in the United Kingdom, dedicated to advancing the field of complementary and alternative medicine. Since its inception in 2020, this journal has rapidly gained recognition, achieving a prestigious Q1 ranking in the category of Complementary and Alternative Medicine as of 2023, and ranking #18 out of 105 in the Scopus database, placing it in the 83rd percentile among its peers. The journal’s mission is to disseminate high-quality research that contributes to a better understanding of the efficacy, safety, and practical application of complementary therapies. With its open-access model, BMC Complementary Medicine and Therapies ensures that valuable research findings are freely accessible to researchers, healthcare practitioners, and students alike, fostering collaboration and innovation across disciplines. The journal publishes original research, reviews, and clinical studies, providing a comprehensive platform for the exploration of diverse therapeutic modalities.

Explore - The Journal of Science and Healing is a reputable publication by Elsevier Science Inc, dedicated to advancing the fields of complementary and alternative medicine, chiropractic practices, and health professions. With an ISSN of 1550-8307 and E-ISSN of 1878-7541, this journal cultivates a dynamic platform for researchers, practitioners, and scholars to disseminate innovative findings, theoretical advancements, and clinical applications across a range of interdisciplinary studies. Covering a broad spectrum from 2005 to 2024, it holds esteemed rankings in notable categories such as Chiropractics (Q2), Complementary and Alternative Medicine (Q2), and Nursing (Q2), underscoring its commitment to quality scholarship and impactful research. While currently operating under a subscription model, the journal aims to foster discourse and collaboration within the health sciences community, ultimately contributing to enhanced patient care and wellness strategies. Explore offers invaluable insights for those at the forefront of science and healing, ensuring its role as a vital resource in shaping the future of these evolving fields.

Welcome to the Journal of Pharmacopuncture, an esteemed publication dedicated to advancing the field of pharmacopuncture—a unique approach integrating principles of acupuncture and pharmacology. Published by the Korean Pharmacopuncture Institute in South Korea, this Open Access journal has been a vital resource for researchers and practitioners since 1997. With an impactful presence in the academic landscape, it holds a commendable Q2 ranking in Complementary and Alternative Medicine and a Q3 rank in Pharmacology as of 2023. The journal aims to disseminate groundbreaking research, innovative techniques, and critical reviews that enhance the understanding and applications of pharmacopuncture in modern medicine. As a pivotal source for both academics and industry professionals, the Journal of Pharmacopuncture is key for those eager to explore the intersection of traditional methods and contemporary scientific inquiry.

Journal of the Chinese Medical Association, published by LIPPINCOTT WILLIAMS & WILKINS, is a prominent peer-reviewed journal in the field of general medicine, specifically focused on advancements and research within the Chinese medical community. Established in 2003 and with a scope that spans diverse medical disciplines, this journal has positioned itself as a key resource for medical professionals, researchers, and academics interested in both clinical practices and health policy in Taiwan and the broader context of Asian medicine. With an impressive Scopus ranking of 69 out of 636 in the general medicine category and a notable percentile rank of 89th, the journal is recognized for its contributions to medical science. Although it does not currently provide open access options, it continues to maintain a robust presence through its high-quality publications and rigorous peer-review process aimed at fostering innovation and sharing critical insights across the medical field. Researchers and students alike will find this journal an invaluable platform for disseminating their findings and engaging with current medical discourse.

COMPLEMENTARY THERAPIES IN MEDICINE, published by Churchill Livingstone, is a premier Open Access journal that has been at the forefront of advancing knowledge in the fields of complementary and alternative medicine since its inception in 1993. With a strong impact in health professions, nursing, and complementary therapies, this journal holds a prestigious spot in the top quartile rankings for 2023, including Q1 classifications in Advanced and Specialized Nursing, Complementary and Alternative Medicine, and Complementary and Manual Therapy. Its Scopus rankings further attest to its significance, being ranked #1 in Complementary and Manual Therapy with an impressive 97th percentile. The journal's commitment to accessibility is underscored by its Open Access policy since 2021, ensuring that researchers, professionals, and students have unrestricted access to high-quality research that informs practice and policy. With a focus on evidence-based approaches, the journal serves as an essential resource for those looking to integrate complementary therapies into holistic healthcare strategies.

Advances in Integrative Medicine is a prestigious academic journal published by Elsevier, dedicated to the field of Complementary and Alternative Medicine. With an ISSN of 2212-9588 and an E-ISSN of 2212-9596, this journal has gained recognition for its high-quality research contributions, achieving a commendable Q2 ranking in the 2023 category of Complementary and Alternative Medicine according to Scopus, placing it at #39/105 in its field with a 63rd percentile ranking. Since its inception in 2014, the journal has been committed to advancing the understanding of integrative medicine practices through rigorous peer-reviewed research, systematic reviews, and innovative methodologies. Although it does not offer open access options, it remains a vital resource for researchers, professionals, and students interested in the latest evidence-based approaches within this dynamic and evolving area of healthcare. Based in Australia, with operations located at RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, Advances in Integrative Medicine continues to serve as a leading platform for scholarly discourse, fostering advancements that can enhance patient care and therapeutic outcomes.

The Journal of Evidence-Based Integrative Medicine is a prestigious publication dedicated to advancing the field of complementary and alternative medicine, published by SAGE Publications Inc. With an impressive Q1 ranking in the field and a Scopus rank of #21 out of 105, this journal positions itself at the forefront of research, achieving a notable 80th percentile performance. Since its transition to Open Access in 2018, it has provided a platform for researchers, professionals, and students to disseminate and access high-quality evidence-based studies that fuse traditional and modern health practices. The journal is essential for those aiming to explore integrative approaches and their applications in modern healthcare, making significant contributions to the dialogue surrounding holistic treatment methodologies. Published in the United Kingdom, it covers a wide array of topics related to integrative medicine and aims to facilitate collaboration and knowledge-sharing across disciplines.

PHARMACEUTICAL BIOLOGY, published by Taylor & Francis Ltd, is a prominent open-access journal that has been a cornerstone of research in the life sciences since its convergence in 1961. With a strong focus on Complementary and Alternative Medicine, Pharmaceutical Science, and Drug Discovery, this journal is dedicated to disseminating groundbreaking research that intersects pharmaceuticals and biology. Acknowledged for its rigorous peer-review process, it holds a prestigious Q1 ranking in Pharmaceutical Science and exemplifies the commitment to quality and impact in the field, boasting an impressive Scopus rank of #14/105 in the complementary and alternative medicine category. Researchers keen on advancing their knowledge in these fields will find PHARMACEUTICAL BIOLOGY an invaluable resource, offering accessibility since its shift to open access in 2017. This journal presents a platform for innovative studies that contribute to the evolving understanding of pharmaceutical applications and biological interactions, serving as an essential hub for researchers, professionals, and students alike.

Medical Acupuncture is a dedicated peer-reviewed journal that focuses on the intersection of integrative health practices and traditional medicine, particularly emphasizing acupuncture as an evidence-based therapeutic modality. Published by MARY ANN LIEBERT, INC, this journal serves as a pivotal resource for researchers, clinicians, and students in the field of Complementary and Alternative Medicine. With an ISSN of 1933-6586, it has established itself within the academic community, boasting a 2023 Scopus rank of #61 out of 105 in its category, placing it in the 42nd percentile. Although not an open-access journal, it offers a comprehensive platform for exploring the latest developments, clinical applications, and research findings related to acupuncture and its effectiveness in patient care. As it converges years of knowledge from 2008 to 2024, Medical Acupuncture continues to enhance understanding of the therapeutic potential of acupuncture and foster professional discourse in this vital area of health and wellness.